Johnson & Johnson Consumer IncAugust 12, 2010

FDA 483 - Johnson & Johnson Consumer Inc - August 12, 2010

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Johnson & Johnson Consumer Inc

Record Details

An FDA inspection of Neutrogena Corporation in Los Angeles, CA, revealed a significant quality control deficiency. The firm failed to ensure that drug product production and control records were adequately reviewed by the quality control unit before batch release. Specifically, temperature excursions during mixing for Body Clear Body Wash lots were not identified during batch record review.

Company: Johnson & Johnson Consumer Inc
Inspection Date: August 12, 2010
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations IV
Person: Truong X. Nguyen (Investigator)

Open in Dashboard

ID · 1ad5f0ba-04db-4153-9c1d-1e2d2fedec02